Pharmala Biotech Holdings Inc. (CSE:MDMA)

Pharmala Biotech Holdings Revenue

Pharmala Biotech Holdings had revenue of 280.58K CAD in the quarter ending February 28, 2026, with 92.63% growth. This brings the company's revenue in the last twelve months to 889.57K, up 106.79% year-over-year. In the fiscal year ending August 31, 2025, Pharmala Biotech Holdings had annual revenue of 605.50K, down -41.51%.

• Revenue (ttm): 889.57K
• Revenue Growth: +106.79%
• P/S Ratio: 17.14
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	605.50K	-429.80K	-41.51%
Aug 31, 2024	1.04M	503.29K	94.60%
Aug 31, 2023	532.00K	453.93K	581.44%
Aug 31, 2022	78.07K	-	-
Aug 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error